Since the inaugural meeting in 1999 eCM meetings have been the place where scientists and clinicians meet to bring clinical problems to the scientists, to initiate projects to answer these clinical problems and to translate the solutions back to the clinics to help the patient.
eCM is proud to be the first non USA event endorsed by the Orthopaedic Research Society (ORS) and looks forward to continuing this collaboration.
Europe and USA
eCM XIV: Stem & Progenitor Cells for Musculoskeletal Regeneration has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME) and designated for a maximum of, or up to
13 European CME credits.
The EACCME is an institution of the European Union of Medical
Specialists (UEMS), www.uems.net.
(EACCME credits are recognised by the American Medical Association
towards the Physician's Recognition Award (PRA). To convert
EACCME credit to AMA PRA category 1 credit, contact the AMA).
eCM XIV: Stem & Progenitor Cells for Musculoskeletal Regeneration has been designated for a maximum of, or up to 15 credits for Schweizerischen Gesellschaft für Chirurgie (SGC) and 8 credits for Schweizerischen Gesellschaft für Orthopädie und Traumatologie (SGOT).